论文信息 - A low FEV1 confounds interpretation of FeNO as an eligibility criterion for Dupilumab. - 字舞流文

A low FEV1 confounds interpretation of FeNO as an eligibility criterion for Dupilumab.

A. Malinovschi | A. Michils | A. van Muylem | A. Haccuria | L. Demey | Silvia Pérez-Bogerd | Jeremy Cofino Casanueva